Vianex

PHARMACEUTICAL COMPANY Member of the Giannakopoulos Group

In the centre, Paul Giannakopoulos. On his left, his brother Thanasis and on his right, Costas.

For more than 90 years the Giannakopoulos family has been making history in the Greek pharmaceutical world.
  • 1924
    image
    Dimitris Giannakopoulos opened one of the first pharmacies in Athens.
  • 1960
    image
    Paul Giannakopoulos founded PHARMAGIAN, a company which expanded rapidly in Greece and also abroad as a representative of major international pharmaceutical companies.
  • 1971
    image
    PHARMAGIAN became a societé anonyme and was renamed VIANEX. The company developed immediately and gained recognition when international pharmaceutical companies such as Merck & Co (USA), Takeda Chemical Industries (Japan), Boots (UK), Sigma Tau Industries (Italy) etc. entrusted VIANEX to represent their products in the Greek market.
  • 1977
    image
    The company began its manufacturing activities with the establishment of Plant A.
  • 1983
    image
    The company signed an agreement with the Merck & Co group.
  • 1983
    image
    The Winthrop-Sterling factory was modernised and became VIANEX’s Plant B in Pallini.
  • 1985
    image
    The Upjohn company's factory production line was expanded and it became VIANEX’s Plant C.
  • 1995
    image
    The subsidiary company VIAN SA was founded to handle existing non-prescription pharmaceuticals and OTC products.
  • 1997
    image
    VIANEX bought the Varibobi premises of the Hoechst company to house its Headquarters and the Distribution Center for its finished products.
  • 1999
    image
    The antibiotics production unit of the Institute of Pharmaceutical Research and Technology in Patras Industrial Zone was fully upgraded to meet the company’s strict standards for production and became VIANEX’s Plant D.
  • 2011
    image
    VIANEX was approved as a supplier by the World Health Organization.
  • 2013
    image
    VIANEX signed an agreement with Lilly to to produce 10,000,000 units of vancomycin annually and to export 100% of this production to China.
  • 2019
    Acquisition of PHARMANEL S.A.
  • 2020
    Merge of VIAN S.A. & PHARMANEL S.A.
VIANEX continues to maintain its position at the top of the Greek pharmaceutical industry.